Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

Vanessa Williams, the celebrated actress and singer known for her iconic role as Wilhelmina Slater on the hit series Ugly ...

Up until recently, all three GLP-1 drugs for weight loss were only available in injectable form. However, the FDA approved ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

A large review found that people who stopped taking GLP-1 drugs regained weight nearly twice as fast as people who gave up ...

Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in VANQUISH ...

FDA moves to strike suicide risk warnings from Saxenda, Wegovy, and Zepbound labels after analysis finds no increased risk.

Research has shown that people who stop taking GLP-1 drugs, such as Ozempic and Wegovy, typically experience weight regain within 2 years.

Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...

Eli Lilly and Novo Nordisk make the world’s most popular weight loss drugs. These injectable products have generated ...